Examples of using Tracleer in English and their translations into Hungarian
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Programming
-
Official/political
-
Computer
In systemic sclerosis with digital ulcers, two studies have compared Tracleer with placebo in a total of 312 patients.
Treatment with Tracleer should only be initiated
Tracleer 32 mg dispersible tablets are pale yellow to off-white,
Tracleer treatment should be started at a dose of 62.5 mg twice a day for four weeks
Tracleer can also be used in adults with systemic sclerosis in whom poor blood circulation caused by the disease has led to the development of‘digital ulcers'(sores on the fingers and toes).
Tracleer treatment should be initiated at a dose of 62.5 mg twice daily for 4 weeks
If it is possible that you could become pregnant, use a reliable form of birth control(contraception) while you are taking Tracleer.
In systemic sclerosis with digital ulcers, two studies have compared Tracleer film-coated tablets with placebo in a total of 312 adults.
Similar results were seen in the second study after 24 weeks, but Tracleer did not have any effect on digital ulcer healing.
pregnant while taking Tracleer, because it cannot be excluded that Tracleer may harm the foetus.
pre-treatment values continuing or re- introducing Tracleer according to the conditions described below should be considered.
Tracleer should not be used concomitantly with glibenclamide,
If you forget to take Tracleer If you forget to take Tracleer, take a dose as soon as you remember, then continue to
Before the initiation of Tracleer treatment in women of child-bearing potential,
The dosage of these products may need to be adjusted after initiation, dose change or discontinuation of concomitant Tracleer treatment.
Therefore, you should not take Tracleer if you are pregnant
If you have the impression that the effect of Tracleer is too strong
Concomitant administration of both a CYP3A4 inhibitor and a CYP2C9 inhibitor with Tracleer should be avoided(see section 4.5).
Each Tracleer 32 mg dispersible tablets contains 3.7 mg of Aspartame(E951) which is a source of phenylalanine.
In systemic sclerosis with digital ulcers, Tracleer was more effective at reducing the development of new digital ulcers than placebo.